Blue Square Asset Management’s AbbVie ABBV Stock Holding History

Blue Square Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,460	Closed	-$1.46M	–	82
2021 Q1	$1.46M	Buy	13,460 +662	+5%	+$70.8K	0.93%	28
2020 Q4	$1.37M	Sell	12,798 -4,776	-27%	-$459K	0.92%	28
2020 Q3	$1.54M	Buy	17,574 +3,594	+26%	+$338K	1.06%	31
2020 Q2	$1.37M	Sell	13,980 -3,032	-18%	-$267K	0.95%	27
2020 Q1	$1.3M	Buy	17,012 +8,257	+94%	+$703K	1.2%	26
2019 Q4	$775K	Sell	8,755 -1,544	-15%	-$128K	0.6%	45
2019 Q3	$780K	Buy	+10,299	New	+$706K	0.61%	39

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Blue Square Asset Management's ABBV Position: Q2 2021 in Review

Blue Square Asset Management sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 13,460 shares — an estimated $1.46M sold.

Blue Square Asset Management first reported a position in ABBV in Q3 2019 and held it in 7 quarters. The position peaked at $1.54M in Q3 2020. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Blue Square Asset Management reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
Blue Square Asset Management sold 13,460 AbbVie shares in Q2 2021, an estimated $1.46M.
Blue Square Asset Management first reported a position in AbbVie in Q3 2019 and held it in 7 quarters.
Blue Square Asset Management's AbbVie position peaked at $1.54M in Q3 2020.
2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Blue Square Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.